Answers are grounded in this paper and cite their sources.
Biomarkers are defined as measurable objective indicators that can be used to assess normal physiological process, pathological process and/or tissue response to pharmacological therapeutic agents. In this review article, we address the most notable structural changes encountered in DME patients and their impact on treatment planning and outcomes.
No takes yet. Share an insight, caveat, or question.
Mostafa et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: